Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India
· Delayed Price · Currency is INR 1,586.70
-40.70 (-2.50%)
Sep 26, 2025, 3:29 PM IST
NSE:SUNPHARMA Revenue
Sun Pharmaceutical Industries had revenue of 138.51B INR in the quarter ending June 30, 2025, with 9.47% growth. This brings the company's revenue in the last twelve months to 537.77B, up 9.28% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B with 8.42% growth.
Revenue (ttm)
537.77B
Revenue Growth
+9.28%
P/S Ratio
7.08
Revenue / Employee
12.51M
Employees
43,000
Market Cap
3,807.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 525.78B | 40.82B | 8.42% |
| Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
| Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
| Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
| Mar 31, 2021 | 334.98B | 6.61B | 2.01% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Divi's Laboratories | 96.52B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 225.51B |
| Mankind Pharma | 129.10B |
| Zydus Lifesciences | 236.08B |
| Fortis Healthcare | 80.94B |
| Alkem Laboratories | 133.04B |
| Aurobindo Pharma | 320.25B |
Sun Pharmaceutical Industries News
- 3 days ago - Morgan Stanley reiterates overweight on Sun Pharma with Rs 1,948 target price, says well placed in chronic portfolio and specialty expansion - Business Upturn
- 4 days ago - Jefferies reiterates buy on Sun Pharma with Rs 2,070 target, says new launches and India focus to sustain growth - Business Upturn
- 10 days ago - Nifty top gainers today, September 18: Eternal, HDFC Life, Sun Pharma, Cipla, Infosys and more - Business Upturn
- 10 days ago - ICICI Bank, PNB Housing, Sun Pharma, D-Mart, Shriram Finance among top picks with 15–35% upside, say brokerages - Business Upturn
- 10 days ago - Sun Pharma share: Citi maintains buy, sees 35% upside on innovation revenue growth and global expansion - Business Upturn
- 18 days ago - Top stocks to watch today, September 10: Bajaj Auto, Eicher Motors, Yes Bank, Sun Pharma and more - Business Upturn
- 19 days ago - Sun Pharma Halol facility classified as “Official Action Indicated” by US FDA - Business Upturn
- 4 weeks ago - Nifty 50 top losers this month, August 2025: Adani Enterprises, Shriram Finance, IndusInd Bank, Sun Pharma and more - Business Upturn